UK-based Martindale Pharma has acquired Viridian Pharma, a UK-based developer and supplier of niche pharmaceutical products, for an undisclosed sum. This acquisition is part of Martindale Pharma’s strategy to expand its product portfolio and actively support further growth of its hospital-initiated medicines product range. Viridian Pharma has developed five products all of which have regulatory approval in the UK and represent first-to-market specialty hospital-prescribed medicines. The prod...